Toxic Adenoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) (→Gender) |
||
| Line 12: | Line 12: | ||
*Similar to any thyroid disease females are more commonly affected by toxic adenoma than males. | *Similar to any thyroid disease females are more commonly affected by toxic adenoma than males. | ||
*In women and men, the prevalence rate of palpable nodules is 5-7% and 1-2%, respectively. | *In women and men, the prevalence rate of palpable nodules is 5-7% and 1-2%, respectively. | ||
*The female-to-male ratio was 14.9:1 for nontoxic AFTNs and 5.9:1 for toxic AFTN patients | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 14:47, 1 September 2017
|
Toxic Adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Template:T On the Web |
|
American Roentgen Ray Society Images of Toxic Adenoma epidemiology and demographics |
|
Risk calculators and risk factors for Toxic Adenoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overveiw
Epidemiology
Demographics
Age
The incidence of toxic adenoma increases with age; the median age at diagnosis is 50 years.
Race
There is no racial predilection to toxic adenoma.
Gender
- Similar to any thyroid disease females are more commonly affected by toxic adenoma than males.
- In women and men, the prevalence rate of palpable nodules is 5-7% and 1-2%, respectively.
- The female-to-male ratio was 14.9:1 for nontoxic AFTNs and 5.9:1 for toxic AFTN patients